Purification and application of bacterially expressed chimeric protein E1E2 of hepatitis C virus

Protein Expression and Purification

Volumn 49, Issue 1, 2006, Pages 95-101

  Xiang, Zhong Hua ^a   Cai, Wei Jia ^a   Zhao, Peng ^a   Kong, Ling Bao ^a   Ye, Lin Bai ^a   Wu, Zheng Hui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

CD81; E1; E2; Hepatitis C virus; Immunization; Virus receptor interaction

Indexed keywords

ANTIBODY; CD81 ANTIGEN; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ARTICLE; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN BINDING;

ANTIBODIES; ANTIGENS, CD; ESCHERICHIA COLI; GENE EXPRESSION; HEPACIVIRUS; HUMANS; PROTEIN BINDING; RECOMBINANT PROTEINS; VIRAL PROTEINS;

ESCHERICHIA COLI; HEPATITIS C VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 33747756144     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.02.013     Document Type: Article

References (28)

1. Racanelli V., and Rehermann B. Hepatitis C virus infection: when silence is deception. Trends Immunol. 24 (2003) 456-464
2. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
3. Kew M., Francois G., Lavanchy D., Margolis H., Van Damme P., Grob P., Hallauer J., Shouval D., Leroux-Roels G., and Meheus A. Prevention of hepatitis C virus infection. J. Viral Hepat. 11 (2004) 198-205
4. Zein C.O., and Zein N.N. Advances in therapy for hepatitis C infection. Microbes Infect. 4 (2002) 1237-1246
5. Dubuisson J. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr. Top. Microbiol. Immunol. 242 (2000) 135-148
6. Op De Beeck A., Cocquerel L., and Dubuisson J. Biogenesis of hepatitis C virus envelope glycoproteins. J. Gen. Virol. 82 (2001) 2589-2595
7. Choukhi A., Pillez A., Drobecq H., Sergheraert C., Wychowski C., and Dubuisson J. Characterization of aggregates of hepatitis C virus glycoproteins. J. Gen. Virol. 80 Pt 12 (1999) 3099-3107
8. Dubuisson J., Hsu H.H., Cheung R.C., Greenberg H.B., Russell D.G., and Rice C.M. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68 (1994) 6147-6160
9. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y.S., Rice C.M., and Dubuisson J. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71 (1997) 697-704
10. Duvet S., Cocquerel L., Pillez A., Cacan R., Verbert A., Moradpour D., Wychowski C., and Dubuisson J. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval. J. Biol. Chem. 273 (1998) 32088-32095
11. Flint M., Dubuisson J., Maidens C., Harrop R., Guile G.R., Borrow P., and McKeating J.A. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 74 (2000) 702-709
12. Michalak J.P., Wychowski C., Choukhi A., Meunier J.C., Ung S., Rice C.M., and Dubuisson J. Characterization of truncated forms of hepatitis C virus glycoproteins. J. Gen. Virol. 78 Pt 9 (1997) 2299-2306
13. Choo Q.L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C., et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91 (1994) 1294-1298
14. Liu J., Zhu L.X., Kong Y.Y., Li G.D., and Wang Y. Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli. World J. Gastroenterol. 11 (2005) 503-507
15. Yurkova M.S., Patel A.H., and Fedorov A.N. Characterisation of bacterially expressed structural protein E2 of hepatitis C virus. Protein Expr. Purif. 37 (2004) 119-125
16. Flint M., Maidens C., Loomis-Price L.D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., and McKeating J.A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73 (1999) 6235-6244
17. Sambrook J., and Russell D. Molecular Cloning: A Laboratory Manual. third ed. (2001), Cold Spring Harbor Laboratory Press, New York
18. Garcia J.E., Puentes A., Suarez J., Lopez R., Vera R., Rodriguez L.E., Ocampo M., Curtidor H., Guzman F., Urquiza M., and Patarroyo M.E. Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells. J. Hepatol. 36 (2002) 254-262
19. Lagging L.M., Meyer K., Owens R.J., and Ray R. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J. Virol. 72 (1998) 3539-3546
20. Triyatni M., Saunier B., Maruvada P., Davis A.R., Ulianich L., Heller T., Patel A., Kohn L.D., and Liang T.J. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J. Virol. 76 (2002) 9335-9344
21. Ciccaglione A.R., Marcantonio C., Costantino A., Equestre M., Geraci A., and Rapicetta M. Expression and membrane association of hepatitis C virus envelope 1 protein. Virus Genes 21 (2000) 223-226
22. Montigny C., Penin F., Lethias C., and Falson P. Overcoming the toxicity of membrane peptide expression in bacteria by upstream insertion of Asp-Pro sequence. Biochim. Biophys. Acta 1660 (2004) 53-65
23. Yan B.S., Liao L.Y., Leou K., Chang Y.C., and Syu W.J. Truncating the putative membrane association region circumvents the difficulty of expressing hepatitis C virus protein E1 in Escherichia coli. J. Virol. Methods 49 (1994) 343-351
24. Owsianka A., Clayton R.F., Loomis-Price L.D., McKeating J.A., and Patel A.H. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J. Gen. Virol. 82 (2001) 1877-1883
25. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
26. Heile J.M., Fong Y.L., Rosa D., Berger K., Saletti G., Campagnoli S., Bensi G., Capo S., Coates S., Crawford K., Dong C., Wininger M., Baker G., Cousens L., Chien D., Ng P., Archangel P., Grandi G., Houghton M., and Abrignani S. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates. J. Virol. 74 (2000) 6885-6892
27. Cocquerel L., Kuo C.C., Dubuisson J., and Levy S. CD81-dependent binding of hepatitis C virus E1E2 heterodimers. J. Virol. 77 (2003) 10677-10683
28. Nakajima H., Cocquerel L., Kiyokawa N., Fujimoto J., and Levy S. Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop. Biochem. Biophys. Res. Commun. 328 (2005) 1091-1100